-
과장
정영신
- 산부인과
- 전문진료 부인과 내시경수술(로봇수술, 단일공 복강경수술, 자궁경수술), 부인과 양성질환(양성종양, 자궁내막증, 자궁근종), 부인암(자궁내막암, 자궁경부암, 난소암)
정영신 과장의 진료시간표
| 진료과/센터 | 월 | 화 | 수 | 목 | 금 | 토 |
|---|---|---|---|---|---|---|
| 산부인과 |
오후 |
오전 |
- 약력
- 학회
- 논문
- 의료진포부
연세대학교 대학원 의학과 박사
연세대학교 신촌세브란스병원 산부인과 전공의
연세대학교 신촌세브란스병원 산부인과 임상강사
연세대학교 신촌세브란스병원 산부인과 임상연구조교수
연세대학교 신촌세브란스병원 산부인과 임상조교수
연세대학교 신촌세브란스병원 산부인과 진료교수
부인종양학 분과전문의
연세대학교 신촌세브란스병원 산부인과 전공의
연세대학교 신촌세브란스병원 산부인과 임상강사
연세대학교 신촌세브란스병원 산부인과 임상연구조교수
연세대학교 신촌세브란스병원 산부인과 임상조교수
연세대학교 신촌세브란스병원 산부인과 진료교수
부인종양학 분과전문의
1. Prognostic value of complete metabolic response on ¹⁸F-FDG-PET/CT after three cycles of neoadjuvant chemotherapy in advanced high-grade serous ovarian cancer. J Gynecol Oncol. 2022 May;33(3):e28
2. Cancer Patient Tissueoid with Self-Homing Nano-Targeting of Metabolic Inhibitor. Adv Sci (Weinh). 2021 Oct 18;e2102640
3. Effects of Korean red ginseng (Panax ginseng C.A. Meyer) on menopausal symptoms in premenopausal women after gynecologic cancer surgery: a double-blind randomized controlled trial. J Altern Complement Med. 2021 Jan;27(1):66-72
4. Mismatch repair status influences response to fertility-sparing treatment of endometrial cancer. Am J Obstet Gynecol. 2021 Apr;224(4):370.e1-370.e13
5. Impact of subcutaneous negative pressure drains on surgical wound healing in ovarian cancer. Int J Gynecol Cancer. 2021 Feb;31(2):245-250
6. Feasibility and efficacy of gonadotropin-releasing hormone agonists for the prevention of chemotherapy-induced ovarian insufficiency in patients with malignant ovarian germ cell tumours (KGOG 3048R). European Journal of Cancer 2020;133:56-65
7. Early Assessment of Response to Neoadjuvant Chemotherapy with 18F-FDG-PET/CT in Patients with Advanced-Stage Ovarian Cancer. Cancer Res Treat. 2020 Oct;52(4):1211-1218
8. Outcomes of non-high grade serous carcinoma after neoadjuvant chemotherapy for advanced-stage ovarian cancer: a Korean gynecologic oncology group study (OV 1708). BMC Cancer 2019;19:341.
9. Outcomes of Non-High Grade Serous Carcinoma after Neoadjuvant Chemotherapy for Advanced-Stage Ovarian Cancer: Single-Institution Experience. Yonsei Med J 2018;59:930-6.
10. Impact of neoadjuvant chemotherapy and postoperative adjuvant chemotherapy cycles on survival of patients with advanced-stage ovarian cancer. PLos One. 2017 Sep 5;12(9):e0183754. doi: 10.1371/journal.pone.0183754. eCollection 2017.
2. Cancer Patient Tissueoid with Self-Homing Nano-Targeting of Metabolic Inhibitor. Adv Sci (Weinh). 2021 Oct 18;e2102640
3. Effects of Korean red ginseng (Panax ginseng C.A. Meyer) on menopausal symptoms in premenopausal women after gynecologic cancer surgery: a double-blind randomized controlled trial. J Altern Complement Med. 2021 Jan;27(1):66-72
4. Mismatch repair status influences response to fertility-sparing treatment of endometrial cancer. Am J Obstet Gynecol. 2021 Apr;224(4):370.e1-370.e13
5. Impact of subcutaneous negative pressure drains on surgical wound healing in ovarian cancer. Int J Gynecol Cancer. 2021 Feb;31(2):245-250
6. Feasibility and efficacy of gonadotropin-releasing hormone agonists for the prevention of chemotherapy-induced ovarian insufficiency in patients with malignant ovarian germ cell tumours (KGOG 3048R). European Journal of Cancer 2020;133:56-65
7. Early Assessment of Response to Neoadjuvant Chemotherapy with 18F-FDG-PET/CT in Patients with Advanced-Stage Ovarian Cancer. Cancer Res Treat. 2020 Oct;52(4):1211-1218
8. Outcomes of non-high grade serous carcinoma after neoadjuvant chemotherapy for advanced-stage ovarian cancer: a Korean gynecologic oncology group study (OV 1708). BMC Cancer 2019;19:341.
9. Outcomes of Non-High Grade Serous Carcinoma after Neoadjuvant Chemotherapy for Advanced-Stage Ovarian Cancer: Single-Institution Experience. Yonsei Med J 2018;59:930-6.
10. Impact of neoadjuvant chemotherapy and postoperative adjuvant chemotherapy cycles on survival of patients with advanced-stage ovarian cancer. PLos One. 2017 Sep 5;12(9):e0183754. doi: 10.1371/journal.pone.0183754. eCollection 2017.
환자에게 꼭 필요한 최선의 치료를 다하도록 꾸준히 노력하겠습니다.